Ad is loading...
SGTRX vs SLMCX
SGTRX vs SLMCX Comparison
Open Charts SGTRX vs SLMCX
Columbia Seligman Global Tech R
Price$69.30
Change+$1.00 (+1.46%)
VolumeN/A
Net Assets2.58B
Columbia Seligman Tech & Info A
Price$128.49
Change+$1.85 (+1.46%)
VolumeN/A
Net Assets14.35B
SGTRX vs SLMCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
SGTRX vs. SLMCX commentary
Jan 18, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGTRX is a Hold and SLMCX is a Hold.
FUNDAMENTALS
Fundamentals
SLMCX has more cash in the bank: 14.4B vs. SGTRX (2.58B). SGTRX (0.00) and SLMCX (0.00) have matching dividends . SGTRX was incepted earlier than SLMCX: SGTRX (22 years) vs SLMCX (42 years). SGTRX is a more actively managed with annual turnover of: 22.00 vs. SLMCX (13.00). SGTRX has a lower initial minimum investment than SLMCX: SGTRX (0) vs SLMCX (2000). SLMCX annual gain was more profitable for investors over the last year : 15.39 vs. SGTRX (13.96). SGTRX (54.45) and SLMCX (52.28) have equivalent 5 years return.
| SGTRX | SLMCX | SGTRX / SLMCX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 22 years | 42 years | - |
| Gain YTD | 3.371 | 3.279 | 103% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.58B | 14.4B | 18% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 13.96 | 15.39 | 91% |
| Returns for 3 years | 7.73 | 5.63 | 137% |
| Returns for 5 years | 54.45 | 52.28 | 104% |
| Returns for 10 years | 154.97 | 136.33 | 114% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EGOCX | 17.63 | 0.15 | +0.86% |
| Allspring Large Cap Core C | |||
| JEMOX | 30.84 | 0.17 | +0.55% |
| JPMorgan Emerging Markets Equity R5 | |||
| BEOIX | 8.21 | N/A | N/A |
| Barrow Hanley Concentrated EM ESG Opps I | |||
| ARIIX | 9.97 | -0.02 | -0.20% |
| AB Global Real Estate Investment II I | |||
| PHLQX | 43.75 | -0.45 | -1.02% |
| PGIM Jennison Health Sciences R6 | |||